Blog

‘Subscription medicine’ has a name, but researchers want rules

Australia lacks the language to describe online platforms that sell prescriptions, including weight-loss injectables, testosterone and hair-loss treatments, and researchers warn this gap is hindering regulatory response and empirical investigation. 
A new paper from Adelaide University published in JME Practical Bioethics introduced the term “commercial digital health platforms” (CDHPs).  
It defined them as vertically integrated services involving trained healthcare professionals who prescribe and dispense prescription pharmaceuticals, and which operate as “digitally native” platforms.  
Lead researcher and bioethicist Dr Hilary Bowman-Smart from Adelaide University’s Australian Centre for Precision Health said CDHPs typically advertise a single solution, such as weight loss or clear skin, using a specific pharmaceutical product, rather than an open-ended diagnostic process or an assessment of the patient’s eligibility. 
“Our concern is that CDHPs take such existing demand, amplify and reinforce it, and position a specific pharmaceutical as the optimal solution,” the report read.  
Referring to these platforms as “direct-to-consumer” potentially negated both the platforms’ ability to drive demand and suggested that the models bypassed clinician oversight and involvement, researchers argued. 
High convenience, often-on-demand availability, and asynchronous care not only increase the risk of adverse outcomes but also affect trust and therapeutic outcomes due to fragmented care, researchers argued.  
They warned that this created a substantial risk of “enshittification” – reducing quality to maximise profit. 
“This can lead to minimal or no continuity of care with the same professional, and a lack of integration with a treating team,” the research read.  

Related   

Draft telehealth standards call out commercial interests

Peptide-related death spurs call for telehealth inquiry

When telehealth-only clinics… bulk bill?

Research co-author Dr Pett Shih, from the University of Wollongong, said some platforms use familiar shopping tactics, including bundles, reward points, referral programs and discount codes.  
Moshy, for instance, had an advertisement which read: ‘Limited time only: $100 intro offer with code MOSHYINTRO100’. 
Despite CDHPs often promoting their sites as promoting equity in access, researchers pointed to some that engage in “surge pricing” for consultations, a practice commonly seen in ride-hailing apps like Uber, with Updocs’ consultations “subject to change during periods of high demand”. 
While not necessarily engaging in overdiagnosis, Dr Bowman-Smart warned CDHP practitioners might feel pressured to prescribe what patients had asked for or prepaid, limiting their ability to exercise clinical judgement freely – what the researchers defined as “interchangeable gig workers”.  
“Safe healthcare and safe prescribing – the best quality of care usually involves multiple touch points with the healthcare system. These services promote removing those touch points as a benefit,” she said.  
Dr Bowman-Smart said that, based on preliminary research she had conducted, many patients considered CDHP to be “completely disconnected” and “separate” from their other healthcare interactions, often for various reasons.  
“It does seem like many of the patients using these platforms don’t mention it to their regular GP, if they have one, and that might be because they’re embarrassed [or] they’re afraid they might be judged,” she said.  
“Maybe they don’t see it as something their GP needs to know, or they think it’s trivial, like a medical certificate. Or it simply doesn’t occur to them.”  
“Practitioners need to be aware of how rapidly this sector is growing,” she said.  
Dr Bowman-Smart affirmed the “critical” need for open patient conversations and for introducing new or young patients – especially those unfamiliar with healthcare or lacking a regular GP – to the GP’s role. 
“If they are using these [CDHP] platforms as their main point of interaction with healthcare, they’ll see healthcare as transactional,” she said.  
While acknowledging the Australian Commission on Safety and Quality in Health Care draft virtual care standards’ emphasis on treatment decisions free from commercial interests and accurate, up-to-date patient records, she affirmed the need for strong enforcement. 
“We have the opportunity here to set really strong guardrails for this sector,” she said.  
The researchers said regulatory responses were currently reactive, essentially ‘whack-a-mole’ and responding to individual infractions.  
The research team was now building on the findings through an auDA Foundation-funded project, working with young Australians and people in regional, rural and remote areas to better understand their experiences of online healthcare. 
“A lot of these areas are really struggling with a lack of access to a regular GP [and] difficulties getting to an in-person pharmacy, all sorts of reasons that can make engagement with traditional in-person healthcare system[s] difficult,” Dr Bowman-Smart said.  
Although she said telehealth and virtual care were “really valuable” modalities, she cautioned against CDHPs filling healthcare gaps with lower-quality care. 
Read the full report here.  
The post ‘Subscription medicine’ has a name, but researchers want rules appeared first on Medical Republic.

About the author

Asonblog

Add Comment

Click here to post a comment